Moreover, the cisplatin treatment in PKCδ inhibited B16F10 tumor bearing mice did not reduce the body weight, suggesting that PKCδ inhibition has no significant toxicity (Figure 8B). The gene discussed is PRKCD; the disease is neoplasm.